Radiology Oncology Surgical Robots In-Depth Industrial and Market studies Shares, Strategies, and Forecasts, Worldwide, 2016 to 2022
Albany, New York, Feb 09, 2017
"Radiology
Oncology Surgical Robots Market Shares, Strategies, and Forecasts,
Worldwide, 2016 to 2022"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
The
2016 study has 557 pages, 82 tables and figures. Worldwide Radiology
Oncology surgical robot markets are poised to achieve significant
growth as next generation systems provide a way to improve
traditional open surgery and use radiology for cancer surgery. New
systems pinpoint the delivery of radiation precisely, eliminating the
radiological overdosing that has been such a problem previously,
limiting the quantity of radiation that can be delivered.
Radiosurgery
robots take cancer surgery far beyond what has been available,
promising a cure for cancer. Radiology oncology surgical robots use
mechanical mobility and continuous image guidance to remove tumors.
The Accuray CyberKnife® robotic system follows the oncology target
throughout treatment, intelligently delivering sub-millimeter
precision, sparing healthy tissue. A robotic manipulator and a
compact, lightweight linear accelerator, can deliver beams from
thousands of non-coplanar, isocentric or non-isocentric angles.
Treatments have excellent tumor coverage, steep dose gradients, and
tight dose conformality.
The
radiation oncology market is growing globally due to a number of
factors centered around the aging of the population and the benefits
accrued from new technology. The number of new cancer cases diagnosed
annually is projected to increase from 14.9 million in 2015 to 20
million by 2025. The increase in new cases is due to a steadily aging
population. Both developed and developing countries have aging
populations.
Technology
advances improve the precision and applicability of radiotherapy and
radiosurgery. Expanding uses of radiotherapy and radiosurgery
equipment occur because the units are able to treat a broader range
of cases. Advances in hardware and software are creating a market for
replacing an aging installed base. New designs are able to deliver
higher standards of care.
The
rise in cancer cases, together with the increase in sophistication of
new treatment protocols, have created demand for more automated
products. Automation depends on integration of several devices into
clinically practical systems. Integrated systems make treatments
rapid and cost effective.
Technology
advances lead to improvements in patient care. The availability of
advanced, automated and efficient clinical tools in radiation therapy
has brought more precise forms of radiotherapy treatment (IMRT, IGRT,
VMAT, SRS, SBRT, brachytherapy and proton therapy). Technology
includes the EDGE™ and Truebeam™, and the Accuray TomoTherapy H
Series and CyberKnife M6 platforms that enable treatments that reduce
treatment times and increase patient throughput .
International
markets are under-equipped to address the growing cancer incidence.
Patients in many foreign countries must frequently endure long waits
for radiotherapy.
9,000
additional treatment machines will be required by 2020 in developing
countries. China, India and Brazil are estimated to require over
3,800, 1,200 and 400 additional machines. Demand in emerging markets,
coupled with ever increasing incidences of cancer, represent
additional drivers for continued growth.
Radiology
oncology surgical robot market driving forces relate to an
opportunity to achieve change in medical practice regarding the
treatment of cancer. Change would lead to utilization of stereotactic
body radiosurgery more regularly as an alternative to surgery or
other treatments. Radiosurgery is poised to revolutionize the
treatment of cancer by eradicating tumors while not harming
surrounding healthy tissue.
The
ability to use high doses of radiation to precisely eliminate a tumor
while leaving healthy tissue unharmed is compelling. It means that
high doses of radiation can be delivered without killing the person,
that doses of radiation delivered can be enough to kill the cancer
without killing the person, this represents a change in what has been
possible previously.
–
Table of Contents
Radiology Oncology Surgical Robot
Executive Summary 20
Radiology Oncology Surgical Robot Market Driving Forces 20
Surgical Radiology Robotics Market Driving Forces 23
Radiology Surgical Robot Key Procedures As Elements Of Strategy 27
Radiosurgery As Stereotactic Radiotherapy 28
Radiology Oncology Surgical Robots Market Share Analysis 29
Radiology Surgical Robots Market Forecasts 31
Radiology Oncology Surgical Robot Market Driving Forces 20
Surgical Radiology Robotics Market Driving Forces 23
Radiology Surgical Robot Key Procedures As Elements Of Strategy 27
Radiosurgery As Stereotactic Radiotherapy 28
Radiology Oncology Surgical Robots Market Share Analysis 29
Radiology Surgical Robots Market Forecasts 31
1. Radiology Surgical Robot Market
Description and Market Dynamics 35
1.1 Radiotherapy, Radiation Therapy, Radiosurgery, And Brachytherapy Market Description 35
1.1.1 IMRT 36
1.1.2 VMAT 37
1.1.3 IGRT 37
1.1.4 SRS and SBRT 38
1.1.5 Brachytherapy 38
1.1.6 Proton Therapy 39
1.2 Current Radiation Therapy Limitations 40
1.3 Radiology Robotic Surgical Clinical Facilities and Clinical Diagnosis 42
1.3.1 Cancer Robotic Surgery Learning Curves 44
1.3.2 Robotic Radiological Surgery Equipment 44
1.3.3 Medicare and Medicaid Impact 46
1.3.4 Medical Robotic Surgery by Segment 46
1.3.5 Robotic Cancer Surgery 46
1.3.6 Cancer 47
1.4 Brain Tumors 48
1.4.1 Causes of Brain Tumor 49
1.4.2 Tumor Grading 49
1.4.3 Types of Treatment 50
1.4.4 Biopsies 51
1.4.5 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products 51
2D X-Ray Systems Market Driving Forces 53
1.1 Radiotherapy, Radiation Therapy, Radiosurgery, And Brachytherapy Market Description 35
1.1.1 IMRT 36
1.1.2 VMAT 37
1.1.3 IGRT 37
1.1.4 SRS and SBRT 38
1.1.5 Brachytherapy 38
1.1.6 Proton Therapy 39
1.2 Current Radiation Therapy Limitations 40
1.3 Radiology Robotic Surgical Clinical Facilities and Clinical Diagnosis 42
1.3.1 Cancer Robotic Surgery Learning Curves 44
1.3.2 Robotic Radiological Surgery Equipment 44
1.3.3 Medicare and Medicaid Impact 46
1.3.4 Medical Robotic Surgery by Segment 46
1.3.5 Robotic Cancer Surgery 46
1.3.6 Cancer 47
1.4 Brain Tumors 48
1.4.1 Causes of Brain Tumor 49
1.4.2 Tumor Grading 49
1.4.3 Types of Treatment 50
1.4.4 Biopsies 51
1.4.5 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products 51
2D X-Ray Systems Market Driving Forces 53
2. Radiology Oncology Surgical Robot
Market Shares and Market Forecasts 55
2.1 Radiology Oncology Surgical Robot Market Driving Forces 55
2.1.1 Surgical Radiology Robotics Market Driving Forces 58
2.1.2 Radiology Surgical Robot Key Procedures As Elements Of Strategy 62
2.1.3 Radiosurgery Is Stereotactic Radiotherapy 63
2.2 Radiology Oncology Surgical Robots Market Share Analysis 64
2.2.1 Accuray 67
2.2.2 Accuray Clinical Studies 68
2.2.3 Accuray Goal 69
2.2.4 Accuray Revenue 71
2.2.5 Varian 75
2.2.6 Elekta 77
2.2.7 Brainlab 80
2.2.8 Radiology Surgical Robots Market Unit Analysis 81
2.3 Radiology Surgical Robots Market Forecasts 82
2.3.1 Advanced Surgical Robotic Radiation Therapy Systems 86
2.3.2 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products 87
2.4 Cancer Incidence and Radiology Surgery Number of Procedures 88
2.5 Radiology Surgical Robots Regional Analysis 93
2.5.1 US Radiation Oncology Market 94
2.5.2 European Radiation Oncology Market 95
2.5.3 Asia Pacific Market Radiation Oncology Market 95
2.5.4 Accuray in China 96
2.5.5 Advantages of the Accuray Cyberknife treatment in China 99
2.5.6 GE Moves X-Ray Base to China to Tap Growth 100
2.5.7 Japanese Regulatory Approval for Accuray CyberKnife Robotic Full-body Radiosurgery System 101
2.5.8 Japan X-ray Systems Market 101
2.5.9 Philips Expands Global Reach Of X-Ray Solutions 101
2.5.10 Reimbursement Challenges 103
2.1 Radiology Oncology Surgical Robot Market Driving Forces 55
2.1.1 Surgical Radiology Robotics Market Driving Forces 58
2.1.2 Radiology Surgical Robot Key Procedures As Elements Of Strategy 62
2.1.3 Radiosurgery Is Stereotactic Radiotherapy 63
2.2 Radiology Oncology Surgical Robots Market Share Analysis 64
2.2.1 Accuray 67
2.2.2 Accuray Clinical Studies 68
2.2.3 Accuray Goal 69
2.2.4 Accuray Revenue 71
2.2.5 Varian 75
2.2.6 Elekta 77
2.2.7 Brainlab 80
2.2.8 Radiology Surgical Robots Market Unit Analysis 81
2.3 Radiology Surgical Robots Market Forecasts 82
2.3.1 Advanced Surgical Robotic Radiation Therapy Systems 86
2.3.2 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products 87
2.4 Cancer Incidence and Radiology Surgery Number of Procedures 88
2.5 Radiology Surgical Robots Regional Analysis 93
2.5.1 US Radiation Oncology Market 94
2.5.2 European Radiation Oncology Market 95
2.5.3 Asia Pacific Market Radiation Oncology Market 95
2.5.4 Accuray in China 96
2.5.5 Advantages of the Accuray Cyberknife treatment in China 99
2.5.6 GE Moves X-Ray Base to China to Tap Growth 100
2.5.7 Japanese Regulatory Approval for Accuray CyberKnife Robotic Full-body Radiosurgery System 101
2.5.8 Japan X-ray Systems Market 101
2.5.9 Philips Expands Global Reach Of X-Ray Solutions 101
2.5.10 Reimbursement Challenges 103
3. Radiology Surgical Robots Product
Descriptions 105
3.1 Accuray CyberKnife M6 Series 105
3.1.1 Accuray CyberKnife M6 FIM System 111
3.1.2 Accuray CyberKnife® M6™ System 115
3.1.3 Accuray / CyberKnife VSI System 117
3.1.4 Accuray / TomoTherapy System 120
3.1.5 Accuray Clinical Studies 124
3.1 Accuray CyberKnife M6 Series 105
3.1.1 Accuray CyberKnife M6 FIM System 111
3.1.2 Accuray CyberKnife® M6™ System 115
3.1.3 Accuray / CyberKnife VSI System 117
3.1.4 Accuray / TomoTherapy System 120
3.1.5 Accuray Clinical Studies 124
Comments
Post a Comment